116632-23-6

Basic information

• Product Name: no
• Synonyms: Phenol, 3-broMo-5-nitro-;3-Bromo-5-hydroxynitrobenzene;3-Bromo-5-nitrophenol 97%;Phenol, 3-bromo-5-nitro- (Related Reference);3-Bromo-5-nitrophenol96%
• CAS NO: 116632-23-6
• Molecular Formula: C₆H₄BrNO₃
• Molecular Weight: 218.00486
• Mol File: 116632-23-6.mol
• Article Data: 13

Chemical Properties

• Melting Point: 145 °C
• Boiling Point: 310.383 °C at 760 mmHg
• Flash Point: 141.515 °C
• Appearance: /
• Density: 1.881 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 7.38±0.10(Predicted)
• CAS DataBase Reference: no(CAS DataBase Reference)
• NIST Chemistry Reference: no(116632-23-6)
• EPA Substance Registry System: no(116632-23-6)

Safety Data

• Hazardous Substances Data: 116632-23-6(Hazardous Substances Data)

Usage

General Description

3-Bromo-5-nitrophenol is a chemical compound with the molecular formula C6H4BrNO3. It is a yellowish crystalline solid that is commonly used in organic synthesis and as a reagent in chemical reactions. 3-Bromo-5-nitrophenol is also used as an intermediate in the production of pharmaceuticals, pesticides, and dyes. It is classified as a hazardous substance and can cause irritation to the skin, eyes, and respiratory system upon contact. 3-Bromo-5-nitrophenol is also a potential environmental pollutant and should be handled and disposed of with care to minimize its impact on the ecosystem.

Upstream product

• 618-64-4 3-Amino-5-nitro-phenol 
• 10035-10-6 hydrogen bromide 
• 121-88-0 5-Nitro-2-aminophenol 
• 915156-09-1 2-amino-3-bromo-5-nitro-phenol 
• 116296-08-3 acetic acid-(3-hydroxy-5-nitro-anilide) 
• 586-10-7 3-methoxy-5-nitroaniline 
• 586-11-8 3,5-dinitrophenol 
• 6311-60-0 3,5-dibromonitrobenzene 
• 16618-67-0 3-bromo-5-nitroanisole 

Downstream Products

• 128923-99-9 1-(benzyloxy)-3-bromo-5-nitrobenzene 
• 100367-38-2 3-amino-5-bromophenol 
• 1251863-05-4 1-[3-Isopropoxy-5-(7-pyrimidin-2-yl-imidazo[1,2-a]pyridin-3-yl)-phenyl]-3-(2,2,2-trifluoro-ethyl)-urea 
• 1251863-06-5 1-{3-Isopropoxy-5-[7-(5-methyl-[1,3,4]oxadiazol-2-yl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-3-(2,2,2-trifluoro-ethyl)-urea 
• 1251863-09-8 1-{3-[7-(2-Hydroxy-ethoxy)-imidazo[1,2-a]pyridin-3-yl]-5-isopropoxy-phenyl}-3-(2,2,2-trifluoro-ethyl)-urea 
• 1251863-67-8 C₂₆H₃₁F₃N₄O₅ 
• 1251863-81-6 C₁₉H₁₈ClF₃N₄O₂ 
• 1251863-82-7 C₁₉H₂₀BF₃N₄O₄ 
• 1251863-83-8 C₁₉H₁₉N₅O₂ 
• 1251863-08-7 1-[3-isopropoxy-5-(7-[1,3,4]thiadiazol-2-ylimidazo[1,2-a]pyridin-3-yl)phenyl]-3-(2,2,2-trifluoroethyl)urea 
• 1251863-12-3 2-[2-(3-{3-isopropoxy-5-[3-(2,2,2-trifluoroethyl)ureido]phenyl}imidazo[1,2-a]pyridin-7-yl)pyrimidin-4-yl]-2-methylpropionic acid ethyl ester 
• 1251863-13-4 1-(3-{7-[4-(2-hydroxy-1,1-dimethylethyl)pyrimidin-2-yl]imidazo[1,2-a]pyridin-3-yl}-5-isopropoxyphenyl)-3-(2,2,2-trifluoroethyl)urea 
• 1251863-14-5 1-{3-isopropoxy-5-[7-(4-isopropylpyrimidin-2-yl)imidazo[1,2-a]pyridin-3-yl]phenyl}-3-(2,2,2-trifluoroethyl)urea 
• 1251863-15-6 {3-isopropoxy-5-[7-(5-methyl[1,3,4]oxadiazol-2-yl)imidazo[1,2-a]pyridin-3-yl]phenyl}urea 

Related news

Research paperChemical effect of no (cas 116632-23-6) on CH4 oxidation during combustion in O2/no (cas 116632-23-6) environments08/16/2019

The effect of NO on methane oxidation in O2/NO combustion atmosphere was investigated using reactive molecular dynamics (RMD) calculations. It has been observed that, the conversion of NO could accelerate the oxidation of CH4. To provide a detailed description for this phenomenon, the correspond...detailed

Nitrogen Defect Structure and no (cas 116632-23-6)+ Intermediate Promoted Photocatalytic no (cas 116632-23-6) Removal on H2 Treated g-C3N408/15/2019

By heating g-C3N4 powder in the hydrogen atmosphere, nitrogen defects were introduced into the framework of g-C3N4 where the nitrogen atoms in g-C3N4 were reacted and partially removed with hydrogen. The effects of nitrogen defects on the electronic structure, optical properties, generation of r...detailed

Relevant articles and documents

PYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF

Provided are a pyrimidine compound represented by Formula 1, a method of preparing the same, and a pharmaceutical use of the pyrimidine compound for the prevention or treatment of cancer.

Antibacterial Compounds

The present invention provides a compound of the following formula, salts, racemates, diastereomers, enantiomers, esters, carbamates, phosphates, sulfates, deuterated forms and prodrugs thereof. Also provided is the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.

ANTIBACTERIAL COMPOUNDS

The present invention provides a compound of the following formula and salts thereof: Also provided is the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.